Friday, Aadi Bioscience Inc (NASDAQ: AADI) released results from a planned interim analysis on the first third of participants in the ongoing tumor-agnostic PRECISION1 trial of nab-sirolimus in patients with
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results.
Quanex Building Products shares fell 10.7% to $30.95 on Friday.
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 60 points on Friday.
The Dow traded up 0.11% to 37,288.04 while the NASDAQ rose 0.45% to 14,827.63. The S&P 500 also rose, gaining, 0.06% to 4,722.55.
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 75 points on Friday.
The Dow traded down 0.20% to 37,173.96 while the NASDAQ rose 0.31% to 14,806.71. The S&P 500 also fell, dropping, 0.19% to 4,710.37.
Aadi Bioscience Inc (NASDAQ: AADI) shares are trading lower after the company released results from a planned interim analysis on the first third of participants in the ongoing tumor-agnostic PRECISION1 trial of nab-sirolimus in patients with TSC1 or TSC2
Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.